|
Market Closed -
Euronext Paris
11:55:00 2026-10-09 am EDT
|
5-day change | 1st Jan Change | ||
| 142.70 EUR | +0.85% |
|
+2.22% | +19.92% |
| Oct. 08 | Tesco cashes in, OPmobility takes a hit | |
| Sep. 25 | US FDA approves Mirum's drug for rare bone disorder | RE |
Company Valuation: Ipsen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,621 | 8,279 | 8,912 | 9,155 | 9,770 | 11,700 | - | - |
| Change | - | 25.05% | 7.65% | 2.72% | 6.72% | 19.76% | - | - |
| Enterprise Value (EV) 1 | 6,758 | 7,894 | 8,860 | 9,020 | 9,225 | 10,440 | 9,547 | 8,574 |
| Change | - | 16.81% | 12.22% | 1.81% | 2.28% | 13.16% | -8.55% | -10.19% |
| P/E | 10.4x | 12.9x | 14x | 26.7x | 22.4x | 11.9x | 11.8x | 12.2x |
| PBR | 2.42x | - | 2.36x | 2.22x | 2.3x | 2.34x | 1.98x | 1.72x |
| PEG | - | 20.02x | -13.67x | -0.6x | 0.8x | 0x | 13.51x | -3.47x |
| Capitalization / Revenue | 2.31x | 2.74x | 2.85x | 2.69x | 2.49x | 2.55x | 2.48x | 2.4x |
| EV / Revenue | 2.36x | 2.61x | 2.83x | 2.65x | 2.35x | 2.27x | 2.02x | 1.76x |
| EV / EBITDA | 5.8x | 5.86x | 10.1x | 7.52x | 6.67x | 5.42x | 5.23x | 4.77x |
| EV / EBIT | 6.68x | 7.08x | 8.85x | 8.13x | 7.13x | 6.26x | 6.23x | 5.81x |
| EV / FCF | 8.31x | 9.02x | 12.5x | 11.6x | 8.93x | 8.66x | 7.77x | 6.89x |
| FCF Yield | 12% | 11.1% | 8.02% | 8.59% | 11.2% | 11.6% | 12.9% | 14.5% |
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.535 | 1.555 | 1.655 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 1.08% | 1.09% | 1.16% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 12.02 | 12.12 | 11.7 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 12.8% | 12.8% | 14.1% |
| Net sales 1 | 2,869 | 3,025 | 3,128 | 3,401 | 3,929 | 4,590 | 4,717 | 4,879 |
| EBITDA 1 | 1,166 | 1,348 | 881.4 | 1,200 | 1,383 | 1,926 | 1,824 | 1,796 |
| EBIT 1 | 1,011 | 1,115 | 1,001 | 1,109 | 1,294 | 1,668 | 1,533 | 1,475 |
| Net income 1 | 646.6 | 647.5 | 647.2 | 347.3 | 444.5 | 1,012 | 1,025 | 984.1 |
| Net Debt 1 | 137.8 | -384.7 | -52.9 | -134.9 | -544.5 | -1,260 | -2,153 | -3,126 |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 142.70 | 142.70 | 142.70 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 2/11/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.87x | 2.27x | 5.42x | 1.08% | 13.1B | ||
| 33.55x | 12.18x | 25.21x | 0.58% | 1,051B | ||
| 29x | 6.42x | 18.31x | 2.04% | 630B | ||
| 35.19x | 8.13x | 16.76x | 2.51% | 489B | ||
| 111.24x | 5.93x | 25.27x | 2.34% | 359B | ||
| 19.31x | 4.72x | 11.72x | 2.8% | 344B | ||
| 20.06x | 5.27x | 12.98x | 3.02% | 272B | ||
| 20.57x | 4.21x | 12.06x | 2.1% | 246B | ||
| 26.34x | 6.83x | 12.21x | 2.43% | 224B | ||
| -45.84x | 6.75x | 26.31x | 2.18% | 187B | ||
| Average | 26.13x | 6.27x | 16.63x | 2.11% | 381.68B | |
| Weighted average by Cap. | 32.84x | 7.83x | 19.28x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IPN Stock
- Valuation Ipsen
Select your edition
All financial news and data tailored to specific country editions
















